Stockreport

ARS Pharma Retakes Its 50-Day Line In Bullish Post-Earnings Move. Here's Why. [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF Shares of ARS Pharmaceuticals bounded higher Thursday after the company reported an unexpected fourth-quarter metrics. [Read more]